We won an Alzheimer’s Association’s Publication of the Year Award!
We are thrilled to have obtained an Alzheimer’s Association’s Publication of the Year Award in the category «Diversity and Disparities». Congratulations to the team! To read the full paper, click here.
A standardized, multilingual, Mini Linguistic State Examination (MLSE) for classifying and monitoring primary progressive aphasia
PIs: Stefano F. Cappa, Eleonora Catricalà
LiMoN-2: Linguistic Markers of Neurodegeneration in Bilinguals
Swiss National Science Foundation
PIs: Valentina Borghesani, Marcio Soto Añari, Adolfo M. García
Written language impairments in primary progressive aphasia: Difference between Kanji and Kana in Japanese
Tohoku University
PI: Kyoko Suzuki
Comparative analysis of speech characteristics in connected-speech tasks: Insights from healthy Hebrew speakers and three diverse English groups
National Institute on Aging (NIA); Department of Defense (DoD)
PI: Naomi Nevler
Automated speech markers for Korean patients with AD and PD
Alzheimer’s Association; Penn Data Driven Discovery Initiative
PI: Sunghye Cho
Improving brain synchronization and executive functioning in patients with Mild Cognitive Impairment by transcranial alternate current brain stimulation: The Cogmax study
ZonMW Memorabel Grant
PI: Branislava Ćurčić-Blake
Language decline in subjective cognitive impairment: Early detection of dementia
IDEALAB
PI: Branislava Ćurčić-Blake
Inequities of linguistic research on brain health (in Spanish)
One of the greatest public health challenges of our era is the rise of neurodegenerative disorders. Throughout the world, diseases such as Alzheimer’s, Parkinson’s and frontotemporal dementia have high rates of disability and mortality. These conditions affect some 55 million people today, a figure that will double or triple by 2050. This growth will be […]
Of language, brain health, and global inequities
One of the greatest public health challenges of our century lies in the growth of neurodegenerative disorders. Conditions such as Alzheimer’s disease, Parkinson’s disease, and frontotemporal dementia stand as major contributors to disability and mortality in affluent and under-resourced nations alike. Currently affecting over 55 million individuals, their prevalence is expected increase significantly by 2050—especially […]